BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 27176210)

  • 1. (‑)‑Epigallocatechin‑3‑gallate induces apoptosis in human pancreatic cancer cells via PTEN.
    Liu S; Xu ZL; Sun L; Liu Y; Li CC; Li HM; Zhang W; Li CJ; Qin W
    Mol Med Rep; 2016 Jul; 14(1):599-605. PubMed ID: 27176210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PI3K/AKT/mTOR signaling is involved in (-)-epigallocatechin-3-gallate-induced apoptosis of human pancreatic carcinoma cells.
    Liu S; Wang XJ; Liu Y; Cui YF
    Am J Chin Med; 2013; 41(3):629-42. PubMed ID: 23711146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-1 mediates PTEN suppression and enhances cell invasion and proliferation via activation of the IGF-1/PI3K/Akt signaling pathway in pancreatic cancer cells.
    Ma J; Sawai H; Matsuo Y; Ochi N; Yasuda A; Takahashi H; Wakasugi T; Funahashi H; Sato M; Takeyama H
    J Surg Res; 2010 May; 160(1):90-101. PubMed ID: 19560785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA‑93‑5p promotes the progression of human retinoblastoma by regulating the PTEN/PI3K/AKT signaling pathway.
    Cao Y; Xia F; Wang P; Gao M
    Mol Med Rep; 2018 Dec; 18(6):5807-5814. PubMed ID: 30365088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
    Yang J; Zou Y; Jiang D
    Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thymosin alpha 1 suppresses proliferation and induces apoptosis in breast cancer cells through PTEN-mediated inhibition of PI3K/Akt/mTOR signaling pathway.
    Guo Y; Chang H; Li J; Xu XY; Shen L; Yu ZB; Liu WC
    Apoptosis; 2015 Aug; 20(8):1109-21. PubMed ID: 26002438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PTEN regulates angiogenesis through PI3K/Akt/VEGF signaling pathway in human pancreatic cancer cells.
    Ma J; Sawai H; Ochi N; Matsuo Y; Xu D; Yasuda A; Takahashi H; Wakasugi T; Takeyama H
    Mol Cell Biochem; 2009 Nov; 331(1-2):161-71. PubMed ID: 19437103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro-apoptotic effect of epigallo-catechin-3-gallate on B lymphocytes through regulating BAFF/PI3K/Akt/mTOR signaling in rats with collagen-induced arthritis.
    Liu D; Li P; Song S; Liu Y; Wang Q; Chang Y; Wu Y; Chen J; Zhao W; Zhang L; Wei W
    Eur J Pharmacol; 2012 Sep; 690(1-3):214-25. PubMed ID: 22760071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTEN/AKT/mTOR signaling mediates anticancer effects of epigallocatechin‑3‑gallate in ovarian cancer.
    Qin J; Fu M; Wang J; Huang F; Liu H; Huangfu M; Yu D; Liu H; Li X; Guan X; Chen X
    Oncol Rep; 2020 Jun; 43(6):1885-1896. PubMed ID: 32236585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased miR-142 and decreased DJ-1 enhance the sensitivity of pancreatic cancer cell to adriamycin.
    Han GY; Cui JH; Liang S; Li HL
    Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7696-7703. PubMed ID: 30536312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NOTCH1 functions as an oncogene by regulating the PTEN/PI3K/AKT pathway in clear cell renal cell carcinoma.
    Liu S; Ma X; Ai Q; Huang Q; Shi T; Zhu M; Wang B; Zhang X
    Urol Oncol; 2013 Aug; 31(6):938-48. PubMed ID: 21993533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTEN/PI3K/mTOR/B7-H1 signaling pathway regulates cell progression and immuno-resistance in pancreatic cancer.
    Zhang Y; Zhang J; Xu K; Xiao Z; Sun J; Xu J; Wang J; Tang Q
    Hepatogastroenterology; 2013 Oct; 60(127):1766-72. PubMed ID: 24624456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formaldehyde induces the apoptosis of BMCs of BALB/c mice via the PTEN/PI3K/Akt signal transduction pathway.
    Yu G; Wang C; Song X; Liu S; Zhang Y; Fan L; Yang Y; Huang Y; Song J
    Mol Med Rep; 2019 Jul; 20(1):341-349. PubMed ID: 31115571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-214 acts as a potential oncogene in breast cancer by targeting the PTEN-PI3K/Akt signaling pathway.
    Wang F; Li L; Chen Z; Zhu M; Gu Y
    Int J Mol Med; 2016 May; 37(5):1421-8. PubMed ID: 26951965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. JQ1 suppresses tumor growth via PTEN/PI3K/AKT pathway in endometrial cancer.
    Qiu H; Li J; Clark LH; Jackson AL; Zhang L; Guo H; Kilgore JE; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2016 Oct; 7(41):66809-66821. PubMed ID: 27572308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN promotes apoptosis of H2O2‑injured rat nasal epithelial cells through PI3K/Akt and other pathways.
    Jia M; Chen X; Liu J; Chen J
    Mol Med Rep; 2018 Jan; 17(1):571-579. PubMed ID: 29115519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursolic acid attenuates diabetic mesangial cell injury through the up-regulation of autophagy via miRNA-21/PTEN/Akt/mTOR suppression.
    Lu X; Fan Q; Xu L; Li L; Yue Y; Xu Y; Su Y; Zhang D; Wang L
    PLoS One; 2015; 10(2):e0117400. PubMed ID: 25689721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibroblast-derived CXCL12 regulates PTEN expression and is associated with the proliferation and invasion of colon cancer cells via PI3k/Akt signaling.
    Ma J; Sun X; Wang Y; Chen B; Qian L; Wang Y
    Cell Commun Signal; 2019 Sep; 17(1):119. PubMed ID: 31500630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of cell apoptosis and proliferation in pancreatic cancer through PI3K/Akt pathway via Polo-like kinase 1.
    Mao Y; Xi L; Li Q; Cai Z; Lai Y; Zhang X; Yu C
    Oncol Rep; 2016 Jul; 36(1):49-56. PubMed ID: 27220401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EG-VEGF silencing inhibits cell proliferation and promotes cell apoptosis in pancreatic carcinoma via PI3K/AKT/mTOR signaling pathway.
    Yan X; Hui Y; Hua Y; Huang L; Wang L; Peng F; Tang C; Liu D; Song J; Wang F
    Biomed Pharmacother; 2019 Jan; 109():762-769. PubMed ID: 30551529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.